NDRG2基因在贲门腺癌中的甲基化状态及表达

doi:10.3969/j.issn.1004-616x.2014.04.008

癌变·畸变·突变

NDRG2基因在贲门腺癌中的甲基化状态及表达

马洪亮¹，韩立杰²，郭炜³，郭艳丽³，沈素朋³，邝钢^3，*

河北医科大学第四医院麻醉科，河北石家庄050011

收稿日期:2014-02-18 修回日期:2014-06-19 出版日期:2014-07-30 发布日期:2014-07-30
通讯作者: 邝钢，Tel：0311-86095337；E-mail：kuanggang1960@163.com
作者简介:马洪亮(1969- )，男，河北省景县人，副主任技师，研究方向：肿瘤的诊断与治疗。
基金资助:
河北省医学科学研究重大专项(冀财预复[2012]2056号)

Promoter methylation status and expression of NDRG2 gene in gastric cardia adenocarcinoma

MA Hong-liang¹ ，HAN Li-jie²，GUO Wei³，GUO Yan-li³，SHEN Su-peng³，KUANG Gang^3，*

Department of Anesthesiology, the Fourth Hospital of Hebei Medical University, Shijiazhuang 050011

Received:2014-02-18 Revised:2014-06-19 Online:2014-07-30 Published:2014-07-30

摘要/Abstract

摘要：

目的：探讨贲门腺癌(GCA)中NDRG2(N-myc downstream-regulated gene 2)基因启动子区的甲基化状态，并分析其甲基化与表达之间的相关性。方法：应用甲基化特异性PCR(MSP)方法检测97例贲门腺癌组织及相应癌旁组织中NDRG2基因的甲基化状态，应用RT-PCR和免疫组织化学方法检测97例贲门腺癌组织及相应癌旁组织中NDRG2的mRNA和蛋白表达情况。结果：NDRG2基因启动子区在贲门腺癌组织中的甲基化率(49.5%)显著高于癌旁正常组织(5.1%)(P<0.05)，且Ⅲ期和Ⅳ期贲门腺癌患者中NDRG2基因甲基化的比率显著高于Ⅰ期和Ⅱ期患者，低分化组中NDRG2基因发生甲基化的比率显著高于高中分化组。贲门腺癌组织中NDRG2 mRNA表达水平显著低于癌旁正常组织(P<0.05)。贲门腺癌组织中NDRG2蛋白表达阳性率为44.3%(43/97)，显著低于相应癌旁正常组织的蛋白表达94.8%(92/97)(P<0.01)，且贲门腺癌组织中NDRG2蛋白表达缺失与其启动子区的甲基化有明显的相关性(r=-0.510，P<0.01)。结论：NDRG2基因启动子区的高甲基化导致的基因沉默可能是贲门腺癌中此基因表达降低的机制之一。

关键词: 贲门, 腺癌, NDRG2, 甲基化, 表达

Abstract:

OBJECTIVE: To investigate the promoter methylation status of N-myc downstream-regulated gene 2 (NDRG2) and its correlation with mRNA and protein expressions of the gene in gastric cardia adenocarcinoma (GCA). METHODS：MSP method was used to measured the promoter methylation status of NDRG2 in 97 GCA tumor tissues and corresponding normal tissues. RT-PCR and immunohistochemistry were used to examine mRNA and protein expression，respectively，of NDRG2 in 97 GCA tumor tissues and corresponding normal tissues. RESULTS：The promoter methylation frequency of NDRG2 in GCA tumor tissues (49.5%) was significantly increased in comparison to that in corresponding normal tissues (5.1%) (P<0.05). The methylation frequency of NDRG2 in stages Ⅲ and Ⅳ tumor tissues was significantly higher than that in stages Ⅰ and Ⅱ tumor tissues. The methylation frequency of NDRG2 in poorly differentiated group was significantly higher than that in well and moderately differentiated group (P<0.05). NDRG2 mRNA expression in tumor tissues was significantly lower than that in corresponding normal tissues (P<0.05). Positive protein expression of NDRG2 in tumor tissues (44.3%，43/97) was significantly lower than that in corresponding normal tissues (94.8%，92/97) (P<0.01). The protein expression of NDRG2 was inversely correlated with its promoter methylation status in GCA tissues. CONCLUSION：Promoter hypermethylation of NDRG2 may be one of the mechanisms that lead to gene inactivation in gastric cardia adenocarcinoma.

Key words: cardia, adenocarcinoma, N-myc downstream-regulated gene 2, methylation, expression

马洪亮，韩立杰，郭炜，郭艳丽，沈素朋，邝钢. NDRG2基因在贲门腺癌中的甲基化状态及表达[J]. 癌变·畸变·突变, doi: 10.3969/j.issn.1004-616x.2014.04.008.

MA Hong-liang,HAN Li-jie，GUO Wei，GUO Yan-li，SHEN Su-peng，KUANG Gang. Promoter methylation status and expression of NDRG2 gene in gastric cardia adenocarcinoma[J]. Carcinogenesis, Teratogenesis & Mutagenesis, doi: 10.3969/j.issn.1004-616x.2014.04.008.

参考文献

[1] Okuda T，Kondoh H. Identification of new genes Ndr2 and Ndr3 which are related to Nd r1/RTP/Drg1 but show distinct tissue specificity and response to N-myc[J]. Biochem Biophys Res Commun，1999，266(1)：208-215.

[2] 邓艳春，药力波，刘新平，等. 人脑内一含有ACP样结构域新基因的发现[J]. 生物化学与生物物理进展，2001，28(1)： 72-76.

[3] Ku N，Wang L，Li X，et al. N-Myc downstream-regulated gene 2 is involved in p53 mediated apoptosis[J]. Nucleic Acids Res，2008，36(16)：5335-5349.

[4] Burchfield JG，Lennard AJ，Narasimhan S，et al. Akt mediates insulin-stimulated phosphorylation of Ndrg2： evidence for cross-talk with protein kinase C theta[J]. J Biol Chem，2004，279(18)：18623-18632.

[5] Deng Y，Yao L，Chan L，et al. N-Myc downstream-regulated gene 2 (NDRG2) inhibits glioblastoma cell proliferation[J]. Int J Cancer，2003，106(3)：342-347.

[6] Hu XL，Liu XP，Lin SX，et al. NDRG2 expression and mutation in human liver and pancreatic cancers[J]. World J Gastroenterol，2004，10(23)：3518-3521.

[7] Lusis EA，Watson MA，Chicoine MR，et al. Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma[J]. Cancer Res，2005，65(16)：7121-7126.

[8] Lorentzen A，Vogel LK，Lewinsky RH，et al. Expression of NDRG2 is down-regulated in high-risk adenomas and colorectal carcinoma[J]. BMC Cancer，2007，7：192.

[9] Zhang J，Li F，Liu X，et al. The repression of human differentiation related gene NDRG2 expression by Myc via Miz-1-dependent interaction with the NDRG2 core promoter[J]. J Biol Chem，2006，281(51)：39159-39168.

[10] Liu N，Wang L，Liu X，et al. Promoter methylation， mutation，and genomic deletion are involved in the decreased NDRG2 expression levels in several cancer cell lines[J]. Biochem Biophys Res Commun，2007，358(1)：164-169.

[11] Umemoto M，Yokoyama Y，Sato S，et al. Carbonyl reductase as a significant predictor of survival and lymph node metastasis in epithelial ovarian cancer[J]. Br J Cancer，2001，85(7)： 1032-1036.

[12] Bird A. Molecular biology： Methylation talk between histones and DNA[J]. Science，2001，294 (5549)：2113-2115.

[13] Choi JD，Lee JS. Interplay between epigenetics and genetics in cancer[J]. Genomics Inform，2013，11(4)：164-173.

[14] Liu N，Wang L，Liu X，et al. Promoter methylation， mutation，and genomic deletion are involved in the decreased NDRG2 expression levels in several cancer cell lines[J]. Biochem Biophys Res Commun，2007，358(1)：164-169.

[1]	辛雨濛, 梁桓熙, 余悦华, 孙震晓. 基于网络药理学和分子对接法预测甘草干姜汤抗乳腺癌的主要活性成分及作用机制[J]. 癌变·畸变·突变, 2022, 34(1): 7-13.
[2]	国瑞贤, 谢广云, 韩莹. 基于转录组测序方法研究加替沙星对小鼠的肝损伤作用[J]. 癌变·畸变·突变, 2022, 34(1): 20-24.
[3]	赵岩, 孙震晓. 二甲双胍抑制人MDA-MB-231细胞增殖及迁移的体外实验研究[J]. 癌变·畸变·突变, 2022, 34(1): 35-39.
[4]	杨婵君, 陈雯恬, 刘静. 胶原蛋白作为胃癌潜在生物标志物的生物信息学分析[J]. 癌变·畸变·突变, 2021, 33(6): 410-419.
[5]	方煜彤, 张群琛, 洪超群, 陈春发, 陈炯玉, 张任栋, 吴俊东. 乳腺癌中miR-221、miR-222表达水平对GATA3和FOXA1蛋白的影响及其作用机制[J]. 癌变·畸变·突变, 2021, 33(6): 435-441,460.
[6]	孙惠昕, 张茂祥, 王婉莹, 贾海晗, 宋冰冰. 2013—2017年黑龙江省肿瘤登记地区前列腺癌发病死亡情况及趋势分析[J]. 癌变·畸变·突变, 2021, 33(5): 345-348.
[7]	曾卓颖, 吴德生, 鲁晶晶, 廖慧, 赖洪飘, 袁建辉, 胡章立. 雌激素受体α介导氧化磷酸化通路在肺癌发生中的作用[J]. 癌变·畸变·突变, 2021, 33(4): 262-268.
[8]	张世民, 赵瑞君. 蛋白酪氨酸磷酸酶受体J在乳腺癌组织中的表达及其与临床预后的相关性[J]. 癌变·畸变·突变, 2021, 33(4): 276-279,285.
[9]	虞欣璐, 于兵, 王辰, 张红霞, 朱海英. 基于四环素诱导型Hnf1β和Foxa3表达载体的小鼠胚胎成纤维细胞转分化为肝干细胞的实验体系研究[J]. 癌变·畸变·突变, 2021, 33(3): 163-171.
[10]	程斌, 王新宇, 孙钰, 张家泰, 董淑英. 二甲双胍对DEHP和DBP诱导的MCF-7细胞增殖和迁移的抑制作用[J]. 癌变·畸变·突变, 2021, 33(3): 197-202.
[11]	郑珺文, 常晨, 郝佳洁, 蔡岩, 王明荣, 张钰. NEDD4在食管鳞癌中的表达及作用研究[J]. 癌变·畸变·突变, 2021, 33(3): 203-207,224.
[12]	罗娇, 张坤驰, 周莉. 三阴性乳腺癌细胞系MDA-MB-231与其脑转移细胞系中microRNA差异表达分析[J]. 癌变·畸变·突变, 2021, 33(3): 218-224.
[13]	王耀坤, 陈珏晓, 张明远, 邵长利, 杨玉, 商宇. 基于数据库的未分化甲状腺癌基因组变异分析及靶向药物筛选[J]. 癌变·畸变·突变, 2021, 33(1): 53-57.
[14]	王一帆, 许铭炎, 邓小玲. RNA的N⁶-甲基腺嘌呤甲基化在肿瘤发生中作用的研究进展[J]. 癌变·畸变·突变, 2021, 33(1): 77-80.
[15]	李玮玮, 朱莹. 数据挖掘分析MYB家族在乳腺癌中的表达及其预后评估价值[J]. 癌变·畸变·突变, 2020, 32(6): 414-422.

NDRG2基因在贲门腺癌中的甲基化状态及表达

Promoter methylation status and expression of NDRG2 gene in gastric cardia adenocarcinoma

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价